Abstract
RESPIRATORY DEPRESSION IS the most feared of the opioid adverse effects. Nurses in hospitals and all settings nationwide are challenged every day to prevent this life-threatening adverse effect. In 2011, the American Society for Pain Management Nursing (ASPMN) released evidence-based guidelines on monitoring for opioid-induced sedation and respiratory depression in patients receiving opioids for painmanagement in the acute care setting. The guidelines provide answers to frequently asked questions and may be useful in the development of hospital policies and procedures related to this important aspect of patient care. This article describes the development of the guidelines and provides its key recommendationswith implications for nursing practice and the care of patients with pain.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
